Concourse Financial Group Securities, Inc. Nexgel, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NXGL
# of Institutions
13Shares Held
183KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA56.8KShares$174,4980.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$109,6450.01% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA31.8KShares$97,7730.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.6KShares$87,8810.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny25.8KShares$79,3010.0% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $17.1M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...